CANCER LETTERS 581 (2024) 216528 216545 BYPASSING THE TOLLWAY; A NOVEL PATH TO TLR4 INDEPENDENT STEMNESS REGULATION

被引：0
|
作者：
Standing, David [1 ]
Anant, Shrikant [1 ]
机构：
[1] Univ Kansas, Dept Canc Biol, Ctr Canc, Kansas City, KS USA
来源：
CANCER LETTERS | 2024年 / 581卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS17
引用
收藏
页数：2
相关论文
共 7 条
  • [1] CANCER LETTERS 581 (2024) 216528 216542 DEVELOP A NOVEL THERAPY FOR PANCREATIC CANCER
    Li, Min
    CANCER LETTERS, 2024, 581
  • [2] CANCER LETTERS 581 (2024) 216528 216561 REGULATION OF OVARIAN CANCER METASTASIS AND RELAPSE BY THE MICROENVIRONMENT
    Mitra, Anirban K.
    CANCER LETTERS, 2024, 581
  • [3] CANCER LETTERS 581 (2024) 216528 216562 DOUBLECORTIN-LIKE KINASE 1 (DCLK1) PROMOTES PLATINUMRESISTANCE AND IS A NOVEL THERAPEUTIC TARGET FOR OVARIAN CANCER
    Dogra, Samrita
    Elayapillai, Sugantha Priya
    Qu, Dongfeng
    Pitts, Kamille
    Filatenkov, Alexander
    Houchen, Courtney W.
    Berry, William L.
    Moxley, Katherine
    Hannafon, Bethany N.
    CANCER LETTERS, 2024, 581
  • [4] CANCER LETTERS 581 (2024) 216528 216560 MiR-1305 IS A NOVEL ONCOMIRNA THAT PROMOTES OVARIAN CANCER CELL PROLIFERATION BY INTERFERING WITH AUTOPHAGY-MEDIATED CANCER CELL DORMANCY
    Esposito, Andrea
    Ferraresi, Alessandra
    Salwa, Amreen
    Vallino, Letizia
    Garavaglia, Beatrice
    Maheshwari, Chinmay
    Dhanasekaran, Danny N.
    Isidoro, Ciro
    CANCER LETTERS, 2024, 581
  • [5] CANCER LETTERS 581 (2024) 216528 216537 NOS2 AND COX2 PREDICTS POOR OUTCOME IN ER- BREAST CANCER THROUGH IMMUNOSUPPRESSION. NOVEL STRATEGIES TO OVERCOME IMMUNOSUPPRESSION
    Wink, David A., Jr.
    CANCER LETTERS, 2024, 581
  • [6] The Transcription Factor Otc4A Stimulates the Proliferation, Invasion, and Stemness of Colorectal Cancer Cells by Inhibiting the Regulation of miR-7-5p on TLR4
    He, Jinsong
    Duan, Liang
    Xie, Yu
    Wei, Shoujiang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [7] Regulation of the migration of colorectal cancer stem cells via the TLR4/MyD88 signaling pathway by the novel surface marker CD14 following LPS stimulation
    Li, Yufei
    Shi, Jiayi
    Liu, Zhixin
    Lin, Yonggang
    Xie, An
    Sun, Wenxiu
    Liu, Jiaqi
    Liang, Jun
    ONCOLOGY LETTERS, 2024, 27 (02)
1